PMV Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 5 analysts polled by S&P Global, PMV Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $4.00. The average 1-year stock price forecast is 213.73% higher than the current stock price, while the lowest is $3.00 (+135.29%) and the highest is $5.00 (+292.16%).

Price Target: $4.00 (+213.73%)

Analyst Consensus: Strong Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$3.00	$4.00	$4.00	$5.00
Change	+135.29%	+213.73%	+213.73%	+292.16%

* Price targets were last updated on Sep 8, 2026.

Analyst Ratings

The average analyst rating for PMV Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart

Rating	Apr '26	May '26	Jul '26	Aug '26	Sep '26	Oct '26
Strong Buy	5	4	5	5	6	5
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	4	5	5	6	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Robert Burns H.C. Wainwright	H.C. Wainwright	Buy Reiterates $5	Buy	Reiterates	$5	+292.16%	Sep 8, 2026
Unknown Analyst Craig-Hallum No rating	Craig-Hallum	Buy Reiterates $4	Buy	Reiterates	$4	+213.73%	Sep 1, 2026
Jonathan Miller Evercore ISI	Evercore ISI	Buy Maintains $4	Buy	Maintains	$4	+213.73%	Sep 1, 2026
Rick Bienkowski Ladenburg Thalmann & Co.	Ladenburg Thalmann & Co.	Buy Reiterates $3	Buy	Reiterates	$3	+135.29%	Aug 17, 2026
Yaron Werber TD Cowen	TD Cowen	Buy Maintains n/a	Buy	Maintains	n/a	n/a	May 12, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

5.03M

EPS This Year

-1.28

from -1.48

EPS Next Year

-0.97

from -1.28

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	-	-	-	-
Operating Income	-58.29M	-77.04M	-80.13M	-78.83M	-86.21M	-78.52M
Net Income	-57.85M	-73.32M	-68.96M	-58.71M	-77.74M	-75.59M
EPS	-	-	-	-	-1.48	-1.28
Free Cash Flow	-	-	-	-	-73.61M	-56.50M
No. Analysts	-	-	-	-	-	5

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	n/a
Avg	n/a
Low	n/a

Revenue Growth

Chart

Revenue Growth	2027	2028
High	-
Avg	-
Low	-

EPS Forecast

Chart

EPS	2026	2027	2028
High	-1.03
Avg	-1.28
Low	-1.42

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-